345 related articles for article (PubMed ID: 6376630)
21. C1q binding and C1 activation by various isolated cellular membranes.
Storrs SB; Kolb WP; Olson MS
J Immunol; 1983 Jul; 131(1):416-22. PubMed ID: 6602834
[TBL] [Abstract][Full Text] [Related]
22. Effect of plicatic acid on human serum complement includes interference with C1 inhibitor function.
Giclas PC
J Immunol; 1982 Jul; 129(1):168-72. PubMed ID: 6979566
[TBL] [Abstract][Full Text] [Related]
23. Functional analysis of activated C1s, a subcomponent of the first component of human complement, by monoclonal antibodies.
Matsumoto M; Nagaki K
J Immunol; 1986 Nov; 137(9):2907-12. PubMed ID: 2428878
[TBL] [Abstract][Full Text] [Related]
24. Activator-bound C1 is less susceptible to inactivation by C1 inhibition than is fluid-phase C1.
Tenner AJ; Frank MM
J Immunol; 1986 Jul; 137(2):625-30. PubMed ID: 3722818
[TBL] [Abstract][Full Text] [Related]
25. Structural features of the first component of human complement, C1, as revealed by surface iodination.
Villiers CL; Chesne S; Lacroix MB; Arlaud GJ; Colomb MG
Biochem J; 1982 Apr; 203(1):185-91. PubMed ID: 6285892
[TBL] [Abstract][Full Text] [Related]
26. Activation of C1r by proteolytic cleavage.
Ziccardi RJ; Cooper NR
J Immunol; 1976 Feb; 116(2):504-9. PubMed ID: 1249422
[TBL] [Abstract][Full Text] [Related]
27. Leukocyte-derived complement inhibitor. IV. The functional properties of C1 bound to erythrocytes pretreated with leukocyte culture supernatant.
Bernard A; Walter W; Teshima H; Boumsell L; Good RA; Day NK
J Immunol; 1976 Oct; 117(4):1117-26. PubMed ID: 977945
[TBL] [Abstract][Full Text] [Related]
28. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.
Veerhuis R; Janssen I; De Groot CJ; Van Muiswinkel FL; Hack CE; Eikelenboom P
Exp Neurol; 1999 Nov; 160(1):289-99. PubMed ID: 10630213
[TBL] [Abstract][Full Text] [Related]
29. Activation of the first component of complement, C1, by a monoclonal antibody recognizing the C chain of C1q.
Heinz HP; Burger R; Golan MD; Loos M
J Immunol; 1984 Feb; 132(2):804-8. PubMed ID: 6606678
[TBL] [Abstract][Full Text] [Related]
30. Antibody-independent activation of C1, the first component of complement, by cardiolipin.
Kovacsovics T; Tschopp J; Kress A; Isliker H
J Immunol; 1985 Oct; 135(4):2695-700. PubMed ID: 4031497
[TBL] [Abstract][Full Text] [Related]
31. Models for C1. Tools or toys? The real biological challenge.
Colomb MG; Arlaud GJ; Chesne S
Behring Inst Mitt; 1989 Jul; (84):121-8. PubMed ID: 2552979
[TBL] [Abstract][Full Text] [Related]
32. The human complement C1 complex has a picomolar dissociation constant at room temperature.
Tseng Y; Zavodszky P; Schumaker VN
J Immunol; 1997 Jan; 158(2):937-44. PubMed ID: 8993014
[TBL] [Abstract][Full Text] [Related]
33. Fluid-phase interaction of C1 inhibitor (C1 Inh) and the subcomponents C1r and C1s of the first component of complement, C1.
Chesne S; Villiers CL; Arlaud GJ; Lacroix MB; Colomb MG
Biochem J; 1982 Jan; 201(1):61-70. PubMed ID: 6282262
[TBL] [Abstract][Full Text] [Related]
34. Studies on human plasma C1 inactivator-enzyme interactions. I. Mechanisms of interaction with C1s, plasmin, and trypsin.
Harpel PC; Cooper NR
J Clin Invest; 1975 Mar; 55(3):593-604. PubMed ID: 123251
[TBL] [Abstract][Full Text] [Related]
35. Reconstitution of C1 in native proenzyme form and its use in a quantitative C1 activation test.
Cooper NR; Ziccardi RJ
J Immunol; 1977 Nov; 119(5):1664-7. PubMed ID: 915274
[TBL] [Abstract][Full Text] [Related]
36. Antibody density on rat red cells determines the rate of activation of the complement component C1.
Hughes-Jones NC; Gorick BD; Howard JC; Feinstein A
Eur J Immunol; 1985 Oct; 15(10):976-80. PubMed ID: 2996908
[TBL] [Abstract][Full Text] [Related]
37. A molecular mechanism for the activation of the first component of complement by immune complexes.
Schumaker VN; Hanson DC; Kilchherr E; Phillips ML; Poon PH
Mol Immunol; 1986 May; 23(5):557-65. PubMed ID: 3018553
[TBL] [Abstract][Full Text] [Related]
38. Complement activation by immunoglobulin does not depend solely on C1q binding.
Bindon CI; Hale G; Waldmann H
Eur J Immunol; 1990 Feb; 20(2):277-81. PubMed ID: 2311645
[TBL] [Abstract][Full Text] [Related]
39. Determination of C1s-C1 inhibitor complexes in plasma by means of an enzyme linked immunosorbent assay.
Nilsson T; Bäck O
Clin Exp Immunol; 1985 Apr; 60(1):178-82. PubMed ID: 3874014
[TBL] [Abstract][Full Text] [Related]
40. The role of immune complexes in the activation of the first component of human complement.
Ziccardi RJ
J Immunol; 1984 Jan; 132(1):283-8. PubMed ID: 6317744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
